Skip to main content

Security report for medac.de

HQ medac GmbH · Healthcare · Germany

High risk. 8 critical or high findings in GDPR outside view, SSL/TLS and 1 other check.

Security score

36/100

Risk levelHigh

0–100, higher is better. How it is calculated

medac GmbH is a well-established German pharmaceutical company founded in 1970, specializing in improving human health through pharmaceutical products and diagnostics in key medical fields such as Rheumatology, Urology, Hematology, and Oncology. The company operates internationally with subsidiaries and locations in over 90 countries, emphasizing quality and patient care. Their website reflects a professional digital presence with clear business information, multilingual support, and patient-focused content. Technically, the site uses modern web technologies including Alpine.js and Mapbox GL JS, and is built on the Ibexa CMS platform, ensuring good performance and mobile optimization. Security posture is strong with HTTPS enforced, secure login via DocCheck, and cookie consent mechanisms in place, though explicit security policies and vulnerability disclosures are absent. Overall, medac demonstrates a mature digital footprint aligned with its business stature and regulatory compliance.

Scanned

NIS2 and GDPR posture

GDPR outside view
15/ 100 · Critical
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

8 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • Critical

      EU business without adequate privacy measures

      EU businesses are subject to strict GDPR requirements

      What to do: Implement comprehensive GDPR compliance including privacy policy, cookie consent, and data protection measures

    • Critical

      No HTTPS encryption

      GDPR requires appropriate security measures for personal data

      What to do: Implement SSL/TLS certificate for HTTPS

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      No HTTPS Encryption

      Website does not use HTTPS encryption, making all data transmission vulnerable to interception

      What to do: Implement SSL/TLS certificate and redirect all HTTP traffic to HTTPS

  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

Need hands-on remediation? Email guard@offseq.com

Keep watching medac.de

This scan found 23 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. See sample alerts.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
35
Email security
60
DNS health
65
Network security
40
GDPR outside view
15
Average
36

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

medac holds a strong market position as a specialized pharmaceutical provider with a broad international footprint. Their business model focuses on manufacturing and distributing pharmaceutical and diagnostic products, targeting healthcare professionals and patients. The company leverages a network of subsidiaries across Europe and Asia, enhancing market reach and operational capabilities. Growth indicators include a large workforce of over 2,000 employees and active career pages. The company maintains a consistent brand image and transparent communication channels, supported by social media engagement and detailed organizational data. Their strategic focus on niche therapeutic areas with unmet medical needs positions them competitively in the healthcare sector.

Security posture

The website exhibits a solid security foundation with HTTPS and secure authentication via DocCheck integration. Cookie consent is actively managed, reflecting GDPR compliance. No critical vulnerabilities or exposed sensitive data were detected in the HTML content. However, the absence of a public security policy, incident response information, or vulnerability disclosure mechanisms suggests room for improvement in transparency and preparedness. Security headers are not explicitly detailed in the HTML but are likely implemented. The company should consider publishing a security.txt file and enhancing header policies to further strengthen their security posture and stakeholder trust.

Recommendations

  1. Publish a dedicated security policy and incident response page to improve transparency.
  2. Implement and document comprehensive security headers such as Content-Security-Policy and X-Frame-Options.
  3. Introduce a vulnerability disclosure program or security.txt file to encourage responsible reporting.
  4. Regularly audit third-party scripts and cookie consent configurations for compliance and security.
  5. Enhance visibility of data protection officer contact details to support GDPR compliance.

Contact details published on the site

Addresses
Legal name
HQ medac GmbH
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
HQ medac GmbH
Description
medac Gruppe is a privately held international pharmaceutical company founded in 1970 in Germany, focused on improving patient quality of life worldwide by providing medical therapies. Their core areas include Rheumatology, Urology, Hematology, and Oncology.
Key services
Pharmaceutical products, Diagnostics, Therapeutic development, Patient education materials
Content quality
good
Branding
consistent

Technology

Stack
JavaScript, Mapbox GL JS, SVG graphics, Cookie Consent Manager CCM19
Frameworks
Alpine.js (x-data attributes), Custom JS modules
Platforms
Web
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced (canonical URL is https)
  • Cookie consent with opt-in/out
  • No exposed credentials or sensitive data in HTML
  • Secure login via DocCheck iframe

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
CCM19 cookie consent tool
Marketing tools
Cookie Consent Manager CCM19
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is professionally designed and well-structured
  2. Clear focus on pharmaceutical business with international presence
  3. Strong compliance with GDPR and cookie consent requirements
  4. No signs of blocking or WAF interference
  5. Use of modern web technologies and frameworks
  6. Contact information and social media links are transparent and consistent
  7. No visible security vulnerabilities or exposed sensitive data
Technical notes

Notes

The website is built on a modern CMS (Ibexa) with a tech stack including Alpine.js for interactivity and Mapbox GL JS for mapping features. The site uses SVG graphics extensively for icons and branding, contributing to fast load times and scalability. Performance is moderate with good mobile optimization and accessibility features. SEO is supported by structured data (JSON-LD) and meta tags, though some meta descriptions are empty. The cookie consent tool CCM19 is integrated for privacy compliance. Hosting details are not explicit, but the site uses HTTPS and external services like DocCheck for authentication. Overall, the technical implementation supports a professional and user-friendly experience with opportunities for further optimization in security headers and metadata completeness.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with medac.de. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review medac.de.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.